FREDUNPharmaceuticals
Fredun Pharmaceuticals Ltd — Balance Sheet
₹1671.80
-1.27%
Fredun Pharmaceuticals Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 0.47 Cr | 0.47 Cr | 0.45 Cr | 0.44 Cr | — |
| Share Issued | 0.47 Cr | 0.47 Cr | 0.45 Cr | 0.44 Cr | — |
| Net Debt | 166.51 Cr | 104.44 Cr | 83.60 Cr | 58.72 Cr | — |
| Total Debt | 167.15 Cr | 105.51 Cr | 86.55 Cr | 60.66 Cr | — |
| Tangible Book Value | 140.96 Cr | 121.05 Cr | 96.07 Cr | 68.00 Cr | — |
| Invested Capital | 308.53 Cr | 226.98 Cr | 182.92 Cr | 128.72 Cr | — |
| Working Capital | 106.78 Cr | 90.37 Cr | 76.55 Cr | 78.90 Cr | — |
| Net Tangible Assets | 140.96 Cr | 121.05 Cr | 96.07 Cr | 68.00 Cr | — |
| Common Stock Equity | 141.38 Cr | 121.47 Cr | 96.38 Cr | 68.06 Cr | — |
| Total Capitalization | 157.92 Cr | 134.27 Cr | 111.82 Cr | 110.10 Cr | — |
| Total Equity Gross Minority Interest | 141.38 Cr | 121.47 Cr | 96.38 Cr | 68.06 Cr | — |
| Stockholders Equity | 141.38 Cr | 121.47 Cr | 96.38 Cr | 68.06 Cr | — |
| Other Equity Interest | 136.66 Cr | 1.57 Cr | 8.33 Cr | 0.21 Cr | — |
| Capital Stock | 4.72 Cr | 4.70 Cr | 4.53 Cr | 4.43 Cr | — |
| Common Stock | 4.72 Cr | 4.70 Cr | 4.53 Cr | 4.43 Cr | — |
| Total Liabilities Net Minority Interest | 346.03 Cr | 186.13 Cr | 160.90 Cr | 118.93 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 24.85 Cr | 19.30 Cr | 21.25 Cr | 45.18 Cr | — |
| Other Non Current Liabilities | 1000.00 | — | 1000.00 | — | — |
| Non Current Deferred Taxes Liabilities | 4.48 Cr | 4.14 Cr | 3.84 Cr | 1.43 Cr | — |
| Long Term Debt And Capital Lease Obligation | 16.53 Cr | 12.80 Cr | 15.44 Cr | 42.04 Cr | — |
| Long Term Debt | 16.53 Cr | 12.80 Cr | 15.44 Cr | 42.04 Cr | — |
| Long Term Provisions | 3.83 Cr | — | 1.96 Cr | 1.71 Cr | 1.60 Cr |
| Current Liabilities | 321.18 Cr | 166.83 Cr | 139.66 Cr | 73.75 Cr | — |
| Other Current Liabilities | 18.63 Cr | — | 3000.00 | 11.59 Cr | 14.82 Cr |
| Current Debt And Capital Lease Obligation | 150.61 Cr | 92.71 Cr | 71.11 Cr | 18.62 Cr | — |
| Current Debt | 150.61 Cr | 92.71 Cr | 71.11 Cr | 18.62 Cr | — |
| Payables | 151.88 Cr | 65.78 Cr | 62.42 Cr | 51.09 Cr | — |
| Total Tax Payable | 7.12 Cr | — | 4.29 Cr | 2.79 Cr | 1.13 Cr |
| Accounts Payable | 144.77 Cr | 62.95 Cr | 59.34 Cr | 48.62 Cr | — |
| Total Assets | 487.41 Cr | 307.60 Cr | 257.28 Cr | 186.99 Cr | — |
| Total Non Current Assets | 59.46 Cr | 50.40 Cr | 41.07 Cr | 34.34 Cr | — |
| Other Non Current Assets | 1.99 Cr | 1000.00 | 1.62 Cr | -2000.00 | — |
| Investmentin Financial Assets | 4.55 Cr | 28000.00 | 28000.00 | 28000.00 | — |
| Available For Sale Securities | 4.55 Cr | 28000.00 | 28000.00 | 28000.00 | — |
| Goodwill And Other Intangible Assets | 0.43 Cr | 0.42 Cr | 0.31 Cr | 0.06 Cr | — |
| Other Intangible Assets | 0.43 Cr | 0.42 Cr | 0.31 Cr | 0.06 Cr | — |
| Goodwill | 0.00 | — | — | — | — |
| Net PPE | 52.49 Cr | 46.15 Cr | 38.63 Cr | 32.28 Cr | — |
| Gross PPE | 52.49 Cr | 62.30 Cr | 51.03 Cr | 41.92 Cr | — |
| Other Properties | 52.49 Cr | 7.11 Cr | 6.00 Cr | 4.41 Cr | — |
| Current Assets | 427.95 Cr | 257.20 Cr | 216.21 Cr | 152.65 Cr | — |
| Other Current Assets | 3.30 Cr | 1.43 Cr | 0.75 Cr | 0.57 Cr | — |
| Inventory | 239.89 Cr | 175.00 Cr | 150.12 Cr | 46.46 Cr | — |
| Other Receivables | 0.47 Cr | 0.25 Cr | 0.15 Cr | 0.11 Cr | — |
| Accounts Receivable | 177.12 Cr | 64.85 Cr | 34.56 Cr | 90.27 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 7.18 Cr | 2.13 Cr | 3.41 Cr | 2.10 Cr | — |
| Other Short Term Investments | 6.54 Cr | 1.06 Cr | 0.46 Cr | 0.17 Cr | — |
| Cash And Cash Equivalents | 0.64 Cr | 1.07 Cr | 2.95 Cr | 1.94 Cr | — |
| Retained Earnings | — | 43.77 Cr | 28.55 Cr | 18.00 Cr | 11.93 Cr |
| Additional Paid In Capital | — | 71.43 Cr | 54.97 Cr | 45.41 Cr | 27.16 Cr |
| Non Current Pension And Other Postretirement Benefit Plans | — | 2.37 Cr | 1.96 Cr | 1.71 Cr | 1.60 Cr |
| Current Deferred Taxes Liabilities | — | 5.54 Cr | 4.29 Cr | 2.79 Cr | 1.13 Cr |
| Current Provisions | — | 1.11 Cr | 0.71 Cr | 0.34 Cr | 1.42 Cr |
| Other Payable | — | 2.80 Cr | 2.75 Cr | 2.44 Cr | 2.05 Cr |
| Dividends Payable | — | 0.04 Cr | 0.33 Cr | 0.03 Cr | 0.02 Cr |
| Non Current Prepaid Assets | — | 3.82 Cr | 2.13 Cr | 2.00 Cr | 0.68 Cr |
| Accumulated Depreciation | — | -16.15 Cr | -12.40 Cr | -9.64 Cr | -7.50 Cr |
| Construction In Progress | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Machinery Furniture Equipment | — | 32.58 Cr | 23.51 Cr | 15.99 Cr | 13.62 Cr |
| Buildings And Improvements | — | 22.09 Cr | 21.00 Cr | 21.00 Cr | 20.08 Cr |
| Land And Improvements | — | 0.52 Cr | 0.52 Cr | 0.52 Cr | 0.52 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 0.04 Cr | 0.34 Cr | 0.03 Cr | 0.02 Cr |
| Prepaid Assets | — | 13.51 Cr | 26.88 Cr | 13.11 Cr | 0.79 Cr |
| Finished Goods | — | 19.61 Cr | 15.22 Cr | 3.27 Cr | 8.49 Cr |
| Work In Process | — | 56.54 Cr | 38.49 Cr | 12.72 Cr | 7.50 Cr |
| Raw Materials | — | 98.85 Cr | 96.41 Cr | 30.46 Cr | 51.58 Cr |
| Allowance For Doubtful Accounts Receivable | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Accounts Receivable | — | 64.85 Cr | 34.56 Cr | 90.27 Cr | 41.08 Cr |
| Cash Equivalents | — | 0.00 | — | — | 0.11 Cr |
| Cash Financial | — | 1.07 Cr | 2.95 Cr | 1.94 Cr | 0.99 Cr |
| Other Inventories | — | — | -12.36 | -1000.00 | — |
| Other Investments | — | — | — | — | 0.28 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Fredun Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.